GlassScriptPhysician profile
Seth M Lieberman
NPI 1881890119
$7,098.49
in general payments reported to CMS, 2019-2025
13 companies · $222 in 2025
The $222 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,235 · 2020: $486 · 2021: $582 · 2022: $410 · 2023: $536 · 2024: $3,627 · 2025: $222.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,624 · Food and Beverage: $1,761.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,624.00 |
| Food and Beverage | $1,761.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $2,903.44 | 2024 | |
| Acclarent, INC | $1,737.66 | 2019-2023 | Trudi Nav Cable |
| Intersect Ent, INC. | $824.29 | 2019-2021 | |
| Stryker Corporation | $373.50 | 2019-2024 | Direct Inject, Duramatrix, Adherus Autospray Et Dural Sealant |
| Medtronic, INC. | $301.54 | 2022-2024 | Stealthstation S8 Platform, Pteye Parathyroid Detection System |
| Integra Lifesciences Corporation | $248.48 | 2024-2025 | Acclarent Aera, Relieva Spinplus Nav, Inspira Air |
| Neurent Medical Limited | $175.00 | 2024 | Neuromark Radiofrequency Console, Neuromark Device |
| Optinose US, INC. | $148.83 | 2020-2024 | |
| Aerin Medical INC. | $135.63 | 2023 | |
| Spirair, INC. | $129.14 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $73.93 | 2020 | |
| Glaxosmithkline, LLC. | $24.65 | 2021 | |
| Medical Device Business Services, INC. | $22.40 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seth Lieberman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.